US 11464783
Heterocyclic compounds
granted A61KA61K31/54A61K31/541
Quick answer
US patent 11464783 (Heterocyclic compounds) held by Aligos Therapeutics, Inc. expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aligos Therapeutics, Inc.
- Grant date
- Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/54, A61K31/541, A61P, A61P31/20